BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 24815345)

  • 1. Inhibition of p16 tumor suppressor gene expression via promoter hypermethylation in canine lymphoid tumor cells.
    Fujiwara-Igarashi A; Goto-Koshino Y; Mochizuki H; Sato M; Fujino Y; Ohno K; Tsujimoto H
    Res Vet Sci; 2014 Aug; 97(1):60-3. PubMed ID: 24815345
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypermethylation of the death-associated protein kinase CpG island in canine B-cell lymphoid tumors.
    Sato M; Mochizuki H; Goto-Koshino Y; Fujiwara-Igarashi A; Takahashi M; Fujino Y; Ohno K; Tsujimoto H
    Vet Immunol Immunopathol; 2014 Oct; 161(3-4):222-31. PubMed ID: 25193469
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aberrant methylation and silencing of ARHI, an imprinted tumor suppressor gene in which the function is lost in breast cancers.
    Yuan J; Luo RZ; Fujii S; Wang L; Hu W; Andreeff M; Pan Y; Kadota M; Oshimura M; Sahin AA; Issa JP; Bast RC; Yu Y
    Cancer Res; 2003 Jul; 63(14):4174-80. PubMed ID: 12874023
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic significance of the expression levels of the p16, p15, and p14 genes in dogs with high-grade lymphoma.
    Fujiwara-Igarashi A; Goto-Koshino Y; Sato M; Maeda S; Igarashi H; Takahashi M; Fujino Y; Ohno K; Tsujimoto H
    Vet J; 2014 Feb; 199(2):236-44. PubMed ID: 24365070
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of p16 gene expression by histone H3 acetylation in canine lymphoid tumor cell lines.
    Fujiwara-Igarashi A; Tomiyasu H; Igarashi H; Yu Y; Gogo-Koshino Y; Ohno K; Tsujimoto H
    Jpn J Vet Res; 2016 Nov; 64(4):257-263. PubMed ID: 29786175
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High frequency of promoter hypermethylation of RASSF1A and p16 and its relationship to aflatoxin B1-DNA adduct levels in human hepatocellular carcinoma.
    Zhang YJ; Ahsan H; Chen Y; Lunn RM; Wang LY; Chen SY; Lee PH; Chen CJ; Santella RM
    Mol Carcinog; 2002 Oct; 35(2):85-92. PubMed ID: 12325038
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Frequent epigenetic silencing of the CpG island promoter of RASSF1A in thyroid carcinoma.
    Schagdarsurengin U; Gimm O; Hoang-Vu C; Dralle H; Pfeifer GP; Dammann R
    Cancer Res; 2002 Jul; 62(13):3698-701. PubMed ID: 12097277
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Frequent epigenetic inactivation of Rb1 in addition to p15 and p16 in mantle cell and follicular lymphoma.
    Chim CS; Wong KY; Loong F; Lam WW; Srivastava G
    Hum Pathol; 2007 Dec; 38(12):1849-57. PubMed ID: 17900658
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Methylation of the 5' CpG island of the p16/CDKN2 tumor suppressor gene in normal and transformed human tissues correlates with gene silencing.
    Gonzalez-Zulueta M; Bender CM; Yang AS; Nguyen T; Beart RW; Van Tornout JM; Jones PA
    Cancer Res; 1995 Oct; 55(20):4531-5. PubMed ID: 7553622
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of the p16INK4a gene and methylation pattern of CpG sites in the promoter region in rat tumor cell lines.
    Honoki K; Tsujiuchi T; Mori T; Yoshitani K; Tsutsumi M; Takakura Y; Mii Y
    Mol Carcinog; 2004 Jan; 39(1):10-4. PubMed ID: 14694443
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The p16-specific reactivation and inhibition of cell migration through demethylation of CpG islands by engineered transcription factors.
    Zhang B; Xiang S; Zhong Q; Yin Y; Gu L; Deng D
    Hum Gene Ther; 2012 Oct; 23(10):1071-81. PubMed ID: 22738793
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased expression of unmethylated CDKN2D by 5-aza-2'-deoxycytidine in human lung cancer cells.
    Zhu WG; Dai Z; Ding H; Srinivasan K; Hall J; Duan W; Villalona-Calero MA; Plass C; Otterson GA
    Oncogene; 2001 Nov; 20(53):7787-96. PubMed ID: 11753657
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Frequent aberrant methylation of p16INK4a in primary rat lung tumors.
    Swafford DS; Middleton SK; Palmisano WA; Nikula KJ; Tesfaigzi J; Baylin SB; Herman JG; Belinsky SA
    Mol Cell Biol; 1997 Mar; 17(3):1366-74. PubMed ID: 9032263
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epigenetic regulation of the ABCB1 gene in drug-sensitive and drug-resistant lymphoid tumour cell lines obtained from canine patients.
    Tomiyasu H; Goto-Koshino Y; Fujino Y; Ohno K; Tsujimoto H
    Vet J; 2014 Jan; 199(1):103-9. PubMed ID: 24332606
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multi-gene epigenetic silencing of tumor suppressor genes in T-cell lymphoma cells; delayed expression of the p16 protein upon reversal of the silencing.
    Nagasawa T; Zhang Q; Raghunath PN; Wong HY; El-Salem M; Szallasi A; Marzec M; Gimotty P; Rook AH; Vonderheid EC; Odum N; Wasik MA
    Leuk Res; 2006 Mar; 30(3):303-12. PubMed ID: 16185764
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Simultaneous inactivation of the p16, p15 and p14 genes encoding cyclin-dependent kinase inhibitors in canine T-lymphoid tumor cells.
    Fujiwara-Igarashi A; Goto-Koshino Y; Mochizuki H; Maeda S; Fujino Y; Ohno K; Tsujimoto H
    J Vet Med Sci; 2013; 75(6):733-42. PubMed ID: 23343657
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypermethylation of the DLC1 CpG island does not alter gene expression in canine lymphoma.
    Bryan JN; Jabbes M; Berent LM; Arthur GL; Taylor KH; Rissetto KC; Henry CJ; Rahmatpanah F; Rankin WV; Villamil JA; Lewis MR; Caldwell CW
    BMC Genet; 2009 Nov; 10():73. PubMed ID: 19912643
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The methylation locus and frequency pattern on p16 INK4a gene promoter CpG in epidermis of patients with psoriasis].
    Chen M; Cui PG; Yao X; Cao YH; Gong JQ; Li AS; Chen ZQ
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2007 Dec; 24(6):674-6. PubMed ID: 18067081
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Up-regulation of expression and lack of 5' CpG island hypermethylation of p16 INK4a in HPV-positive cervical carcinomas.
    Ivanova TA; Golovina DA; Zavalishina LE; Volgareva GM; Katargin AN; Andreeva YY; Frank GA; Kisseljov FL; Kisseljova NP
    BMC Cancer; 2007 Mar; 7():47. PubMed ID: 17359536
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Methylation of specific CpG sites in the promoter region could significantly down-regulate p16(INK4a) expression in gastric adenocarcinoma.
    Song SH; Jong HS; Choi HH; Kang SH; Ryu MH; Kim NK; Kim WH; Bang YJ
    Int J Cancer; 2000 Jul; 87(2):236-40. PubMed ID: 10861481
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.